Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adaptive Study of IL-2 Dose on Regulatory T Cells in Type 1 Diabetes
NCT01827735Phase 2Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Mar 2013
- Primary completion
- May 2014
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of aldesleukin in type 1 diabetes mellitus (T1D), sponsored by Cambridge University Hospitals NHS Foundation Trust. Started Mar 2013; status: completed.
02
Drugs
aldesleukin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT01827735.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01827735.